WAP
TXG icon

Wealthcare Advisory Partners’s 10x Genomics TXG Stock Holding History

Wealthcare Advisory Partners’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-10,187
Closed -$569K – 744
2023
Q2 		$569K Buy
10,187
+21
+0.2% +$1.14K 0.03% 415
2023
Q1 		$567K Buy
+10,166
New +$475K 0.02% 421
2021
Q2 		– Sell
-256
Closed -$46K – 1766
2021
Q1 		$46K Buy
+256
New +$44.2K ﹤0.01% 904

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Wealthcare Advisory Partners's TXG Position: Q3 2023 in Review

Wealthcare Advisory Partners sold out of 10x Genomics (TXG) in Q3 2023, closing a stake of 10,187 shares — an estimated $569K sold.

Wealthcare Advisory Partners first reported a position in TXG in Q1 2021 and held it in 3 quarters. The position peaked at $569K in Q2 2023. 256 funds tracked by Wall St. Rank hold TXG as of Q3 2023.

  • Wealthcare Advisory Partners reported no remaining 10x Genomics position as of Q3 2023 after selling out during the quarter.
  • Wealthcare Advisory Partners sold 10,187 10x Genomics shares in Q3 2023, an estimated $569K.
  • Wealthcare Advisory Partners first reported a position in 10x Genomics in Q1 2021 and held it in 3 quarters.
  • Wealthcare Advisory Partners's 10x Genomics position peaked at $569K in Q2 2023.
  • 256 funds tracked by Wall St. Rank held 10x Genomics as of Q3 2023.

Based on Wealthcare Advisory Partners's 13F filing for Q3 2023, filed 12 Oct 2023.